Question:
MONOCLONAL ANTIBODY for patients who have FAILED FIRST-LINE THERAPIES for MS
Author: LEIGHTON DWIGHT OBILLOSAnswer:
Natalizumab
0 / 5 Â (0 ratings)
1 answer(s) in total
Author
LEIGHTON DWIGHT OBILLOS
Answer:
0 / 5 Â (0 ratings)
1 answer(s) in total